Uncovering the roots of Parkinson's disease, together
A global basic research initiative
Aligning Science Across Parkinson’s (ASAP) is fostering collaboration and resources to better understand the underlying causes of Parkinson’s disease. With scale, transparency, and open access data sharing, we believe we can accelerate the pace of discovery, and inform the path to a cure.
GP2 Announces New Data Release
GP2’s 5th data release is live on the GP2 dashboard. Complex disease data now consists of 24,935 genotyped participants and monogenic disease data now consists of 722 sequenced participants.
Funding for GP2 Extended Five Years
This exciting announcement means GP2 will be able to expand their focus on underrepresented populations while also providing the resources for researchers to deepen their study of all angles of PD, including the very early stages of PD and Parkinson’s spectrum disorders.
ASAP Launches Catalog
Explore research outputs and tools developed by ASAP-funded programs such as the Collaborative Research Network, Global Parkinson’s Genetics Program, and the Parkinson’s Progression Markers Initiative, in our new Catalog.
A Parkinson’s ‘game changer,’ backed by Michael J. Fox, could lead to new diagnostics and, someday, treatments
STAT highlights how The Parkinson’s Progression Markers Initiative (PPMI) recently discovered how αSyn-SAA could be a novel tool for precision medicine approaches, earlier intervention, and improved clinical trial design for Parkinson’s disease.
Exclusive: Google Cofounder Sergey Brin Has Quietly Donated More Than $1 Billion Toward Parkinson’s Disease
Forbes Magazine spotlights the ASAP initiative and the collective effort to accelerate the pace of discovery and inform the path to a cure for Parkinson’s disease.
GP2 Cohort Dashboard Now Includes New Ancestry Categories
The updated GP2 Cohort dashboard now includes additional ancestry information across cohort samples that have already been processed and shared with the AMP® PD platform.